Search results

Page results

• Faith leaders in Islington call for everyone to be vaccinated

  “Vaccines do not kill, the virus does”: that was the message from local leaders from a variety of different faiths during an event at the newly opened vaccination centre at the Business Design Centre in Islington.

• Covid-19 NHS vaccination centre opens at London’s Business Design Centre

  London’s Business Design Centre opens its doors this week as a large- scale COVID-19 vaccination facility.

• Biatain® dressings for radiotherapy and proton beam therapy skin reactions

  Patient information who have been recommended to use a Biatain® dressing on your skin that has broken down due to your radiotherapy or proton beam therapy treatment.

• John McGrath

  John McGrath is a newly appointed governor as a stakeholder member from North Central London Clinical Commissioning Group (CCG). He is a local GP and has lived and worked in Islington for the last decade in a number of different settings, including multiple GP surgeries as a salaried doctor, local A&E departments and urgent care.

• SUMMIT Study early results feature in The Guardian

  A front page story and patient case study highlight SUMMIT Study early diagnosis outcomes.

• King’s Coronation Medal awarded to our head of operations

  Alison Clements, head of operations, patient flow and EPRR, has received a medal in recognition of her work to support NHS preparations for the Coronation of Charles III and Camilla last May.

• 'Gamechanger' drug for treating obesity cuts body weight by 20%

  In a major study involving UCLH a third of people who took a new drug for treating obesity lost more than one-fifth of their total body weight.

• Dangoor Family’s Exilarch’s Foundation gift to speed up pioneering cancer care at UCLH

  UCLH Charity is delighted to announce that the Dangoor Family’s Exilarch’s Foundation has pledged a £1.2m gift to support the next phase of the development of the CAR T programme at University College London Hospitals NHS Foundation Trust (UCLH). The CAR T Speed Release Project aims to reduce the time between extracting patient’s stem cells and injecting re-engineered CAR T cells back into patients with cancer to fight cancer cells.

• World’s first COVID-19 vaccine alternating dose study launches at UCLH

  The world’s first COVID-19 vaccine study researching alternating doses and intervals of approved vaccines is taking place at UCLH.

• UCLH recruits first participant in Europe to remdesivir outpatient study

  UCLH has recruited the first European participant to a trial looking at treating non-hospitalised Covid-19 patients with the drug remdesivir.